We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$465M
AUM Growth
+$27.7M
Cap. Flow
+$3.84M
Cap. Flow %
0.83%
Top 10 Hldgs %
38.98%
Holding
176
New
13
Increased
40
Reduced
76
Closed
5

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$4.58M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$3.56M
3
ALM
Almonty Industries
ALM
+$2.52M
4
SMR icon
NuScale Power
SMR
+$1.43M
5
NVO
Novo Nordisk
NVO
+$1.29M

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$3.25M
2
SLB icon
SLB Ltd
SLB
+$2.76M
3
CPA icon
Copa Holdings
CPA
+$2.42M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$954K
5
GLW icon
Corning
GLW
+$733K

Sector Composition

Rank Sector Weight
1 Financials 22.72%
2 Technology 20.28%
3 Healthcare 14.33%
4 Industrials 10.95%
5 Energy 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YOU icon
101
Clear Secure
YOU
$5.36B
$561K 0.12%
16,000
-1,000
-6% -$34.1K
ETN icon
102
Eaton
ETN
$174B
$538K 0.12%
1,688
-5
-0.3% -$1.77K
TXO icon
103
TXO Partners LP
TXO
$750M
$534K 0.11%
50,000
+40,000
+400% +$506K
XRAY icon
104
Dentsply Sirona
XRAY
$2.45B
$526K 0.11%
46,040
+20,465
+80% +$240K
MYCF
105
State Street My2026 Corporate Bond ETF
MYCF
$47.5M
$508K 0.11%
20,295
-70
-0.3% -$1.75K
CSX icon
106
CSX Corp
CSX
$93.7B
$491K 0.11%
13,548
– –
BAC.PRL icon
107
Bank of America Series L
BAC.PRL
$3.98B
$488K 0.11%
390
-758
-66% -$954K
DUK icon
108
Duke Energy
DUK
$97.2B
$485K 0.1%
4,141
+979
+31% +$120K
PCH
109
DELISTED
PotlatchDeltic
PCH
$478K 0.1%
12,010
-10
-0.1% -$405
AVGO icon
110
Broadcom
AVGO
$2.02T
$478K 0.1%
1,380
-75
-5% -$26.8K
RIO icon
111
Rio Tinto
RIO
$165B
$467K 0.1%
5,831
-784
-12% -$56.4K
CSCO icon
112
Cisco
CSCO
$479B
$464K 0.1%
6,022
-1,246
-17% -$92.5K
BMY icon
113
Bristol-Myers Squibb
BMY
$131B
$462K 0.1%
8,564
– –
IBB icon
114
iShares Biotechnology ETF
IBB
$9.66B
$447K 0.1%
2,650
-165
-6% -$26.8K
GTY
115
Getty Realty Corp
GTY
$2.06B
$447K 0.1%
16,340
– –
PFE icon
116
Pfizer
PFE
$151B
$423K 0.09%
16,983
-52
-0.3% -$1.31K
SYK icon
117
Stryker
SYK
$129B
$415K 0.09%
1,181
+100
+9% +$36.4K
TMHC
118
DELISTED
Taylor Morrison
TMHC
$412K 0.09%
7,000
– –
SBUX icon
119
Starbucks
SBUX
$122B
$408K 0.09%
4,850
-90
-2% -$7.59K
NBR icon
120
Nabors Industries
NBR
$1.23B
$407K 0.09%
7,500
– –
CRBG icon
121
Corebridge Financial
CRBG
$15.1B
$404K 0.09%
13,385
– –
NEM icon
122
Newmont
NEM
$119B
$404K 0.09%
4,042
-200
-5% -$18.1K
MXL icon
123
MaxLinear
MXL
$6.78B
$392K 0.08%
22,500
– –
CNX icon
124
CNX Resources
CNX
$5.18B
$368K 0.08%
10,000
– –
ELV icon
125
Elevance Health
ELV
$84.9B
$347K 0.07%
990
+41
+4% +$13.9K
3 4
5
6 7

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return
NYLIC
New York Life Insurance Company New York $491M AUM 10.97% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Marathon Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Marathon Capital Management held 176 positions worth $465M, up 6.3% from $437M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Marathon Capital Management's Q4 2025 filing shows 13 new, 40 increased, 76 reduced and 5 closed positions. Its largest new stake was Zoetis: 35,150 shares worth $4.42M. The largest sale was T. Rowe Price, an estimated $3.25M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q4 2025 buy was Zoetis: 35,150 shares worth $4.42M.
  • Marathon Capital Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2025, an estimated $3.56M increase.
  • Marathon Capital Management's biggest Q4 2025 reduction was T. Rowe Price, cutting an estimated $3.25M.
  • Marathon Capital Management fully exited Civitas Resources in Q4 2025, selling an estimated $328K.
  • Marathon Capital Management's ten largest holdings make up 39% of its $465M portfolio in Q4 2025.
  • Marathon Capital Management opened 13 new positions and closed 5 in Q4 2025.
  • Marathon Capital Management's portfolio value rose 6.3% quarter-over-quarter to $465M.

Based on Marathon Capital Management's 13F filing for Q4 2025, filed 29 Jan 2026.